Across three trials, 11 , 12 reductions in exacerbations did not reach statistical significance, and improvements in FEV 1 were modest.
← all excerpts
Multi-Criteria Decision Analysis of Biologics in Chronic Obstructive Pulmonary Disease.
1
—
—
Across three trials, 11 , 12 reductions in exacerbations did not reach statistical significance, and improvements in FEV 1 were modest.